Joining us now is John Coleman, group general counsel at Novo Nordisk. John. Thank you very much for joining us this morning.And look before the court. You have to present this argument, not necessarily that what they presented is false, but it's factually true but misleading. That's a bit difficult to do.So what sort of evidence, surveys and otherwise are you bringing to the court showing that consumers were actually misled by this ad and Novo suffered as a result of it. Good morning, and thank you very mu ...

The maker of Ozempic and Wegovy says its competitor is misleading consumers by citing outdated weight-loss data in advertisements. https://t.co/Q6p0TISfz8 ...